Intestinal microbiota and type 2 diabetes mellitus

• Dzgoeva F.Kh.
• Egshatyan L.V.

AbstractIntestinaL microbiota is an important part of the human immune and neuroendocrine systems. Change in qualitative and quantitative composition of microbiota is associated with many diseases, incLuding obesity, metaboLic syndrome, atheroscLerosis and type 2 diabetes meLLitus. This paper presents effect of various microorganisms and changes in microbiota composition on metaboLic processes in human body, as weLL as possibiLity of microbiota moduLation with the aid of nutritionaL factors, pre- and probiotics, antibiotic therapy and bLood gLucose Lowering drugs.

Keywords:microbiota, microorganism, type 2 diabetes mellitus, metformin, DPP-4 inhibitor, sitagliptin, Janumet Long

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)